Literature DB >> 20857207

Pattern of expression of the CREG gene and CREG protein in the mouse embryo.

Guitang Yang1, Yaling Han, Xiaoxiang Tian, Jie Tao, Mingyu Sun, Jian Kang, Chenghui Yan.   

Abstract

The cellular repressor of E1A-stimulated genes (CREG) is a secreted glycoprotein that inhibits cell proliferation and/or enhances differentiation. CREG is widely expressed in adult tissues such as the brain, heart, lungs, liver, intestines and kidneys in mice. We investigated the level of CREG expression during mouse embryogenesis and its distribution at 18.5 days post coitus (dpc) using immunohistochemical staining with diaminobenzidine, western blotting and reverse transcription-polymerase chain reaction. CREG expression was first detected in mouse embryos at 4.5 dpc. It was expressed at almost all stages up to 18.5 dpc. The level of CREG was found to increase gradually and was highest at 18.5 dpc. Western blotting showed that the CREG protein was expressed at higher levels in the brain, heart, intestines and kidneys than in the lungs and liver at 18.5 dpc. In 9.5 dpc embryos, CREG was expressed only in the endothelial cells of blood vessels, after the vascular lumen had formed. With advanced differentiation, vascular smooth muscle cells developed in the embryonic vascular structures; the expression of smooth muscle α-actin protein and CREG were positive and increased gradually in 10.5 dpc embryonic vessels. CREG expression in the embryonic blood vessels peaked at 15.5 dpc and was reduced slightly at 18.5 dpc. These results indicate that CREG is expressed during mouse embryogenesis and might participate in the differentiation of these organs during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857207     DOI: 10.1007/s11033-010-0340-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  23 in total

1.  The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells.

Authors:  E Veal; R Groisman; M Eisenstein; G Gill
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

Review 2.  Development of tubular and glomerular cells of the kidney.

Authors:  L Sorokin; P Ekblom
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

3.  Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts.

Authors:  Ya-Ling Han; Peng Guo; Ming-Yu Sun; Liang Guo; Bo Luan; Jian Kang; Cheng-Hui Yan; Shao-Hua Li
Journal:  Genes Cells       Date:  2008-08-06       Impact factor: 1.891

4.  A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.

Authors:  E Veal; M Eisenstein; Z H Tseng; G Gill
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  The cellular repressor of E1A-stimulated genes mediates glucocorticoid-induced loss of the type-2 IGF receptor in ileal epithelial cells.

Authors:  P V Gordon; J B Paxton; N S Fox
Journal:  J Endocrinol       Date:  2005-05       Impact factor: 4.286

6.  PSM2, a novel protein similar to MCAF2, is involved in the mouse embryonic and adult male gonad development.

Authors:  Huan Cai; Jiarui Hu; Ping Song; Wuming Gong
Journal:  Mol Biol Rep       Date:  2006-09       Impact factor: 2.316

7.  Towards a human repertoire of monocytic lysosomal proteins.

Authors:  A Journet; A Chapel; S Kieffer; M Louwagie; S Luche; J Garin
Journal:  Electrophoresis       Date:  2000-10       Impact factor: 3.535

8.  Profiles of PrKX expression in developmental mouse embryo and human tissues.

Authors:  Wei Li; Zu-Xi Yu; Robert M Kotin
Journal:  J Histochem Cytochem       Date:  2005-05-06       Impact factor: 2.479

9.  CREG, a new regulator of ERK1/2 in cardiac hypertrophy.

Authors:  Li Xu; Jun-Ming Liu; Lan-Ying Chen
Journal:  J Hypertens       Date:  2004-08       Impact factor: 4.844

10.  Borealin is differentially expressed in ES cells and is essential for the early development of embryonic cells.

Authors:  Qianjun Zhang; Ge Lin; Yifang Gu; Jianjun Peng; Zaoyan Nie; Yuelong Huang; Guangxiu Lu
Journal:  Mol Biol Rep       Date:  2008-03-03       Impact factor: 2.316

View more
  6 in total

1.  Homeostatic plasticity fails at the intersection of autism-gene mutations and a novel class of common genetic modifiers.

Authors:  Özgür Genç; Joon-Yong An; Richard D Fetter; Yelena Kulik; Giulia Zunino; Stephan J Sanders; Graeme W Davis
Journal:  Elife       Date:  2020-07-01       Impact factor: 8.140

2.  Gene expression changes of interconnected spared cortical neurons 7 days after ischemic infarct of the primary motor cortex in the rat.

Authors:  Edward T R Urban; Scott D Bury; H Scott Barbay; David J Guggenmos; Yafeng Dong; Randolph J Nudo
Journal:  Mol Cell Biochem       Date:  2012-07-21       Impact factor: 3.396

3.  Up-Regulation of CREG Expression by the Transcription Factor GATA1 Inhibits High Glucose- and High Palmitate-Induced Apoptosis in Human Umbilical Vein Endothelial Cells.

Authors:  Yanxia Liu; Xiaoxiang Tian; Yang Li; Dan Liu; Meili Liu; Xiaolin Zhang; Quanyu Zhang; Chenghui Yan; Yaling Han
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

4.  DNA hypermethylation: A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction.

Authors:  Yanxia Liu; Xiaoxiang Tian; Shan Liu; Dan Liu; Yang Li; Meili Liu; Xiaolin Zhang; Chenghui Yan; Yaling Han
Journal:  Redox Biol       Date:  2020-01-31       Impact factor: 11.799

5.  Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

Authors:  Jie Deng; Yaling Han; Mingyu Sun; Jie Tao; Chenghui Yan; Jian Kang; Shaohua Li
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

6.  Comprehensive identification of novel proteins and N-glycosylation sites in royal jelly.

Authors:  Lan Zhang; Bin Han; Rongli Li; Xiaoshan Lu; Aiying Nie; Lihai Guo; Yu Fang; Mao Feng; Jianke Li
Journal:  BMC Genomics       Date:  2014-02-16       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.